Metallo-β-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: Prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 4, 2002, Pages 503-511

  Yan, Jing Jou ^a   Ko, Wen Chien ^a   Chuang, Chin Luan ^a   Wu, Jiunn Jong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM COLONY; BACTERIUM ISOLATE; CITROBACTER; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME ANALYSIS; ENZYME SYNTHESIS; ESCHERICHIA COLI; HEALTH CARE FACILITY; HORIZONTAL GENE TRANSFER; HUMAN; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PATIENT TRANSPORT; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEUS; RIBOTYPING; SEQUENCE ANALYSIS; SERRATIA; SOUTHERN BLOTTING; TAIWAN; UNIVERSITY HOSPITAL;

BETA-LACTAMASES; CITROBACTER FREUNDII; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; TAIWAN;

EID: 0036798669     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Livermore, D. M. (1995). β-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8, 557-84.
2. Jacoby, G. A. & Medeiros, A. A. (1991). More extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 35, 1697-704.
3. Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H. et al. (1994). Molecular characterization of an entero-bacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrobial Agents and Chemotherapy 38, 71-8.
4. IMP allelic variants carried by gene cassettes of different phylogeny. Antimicrobial Agents and Chemotherapy 44, 1229-35.
5. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrobial Agents and Chemotherapy 43, 1584-90.
6. Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J. D. et al. (2000). Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrobial Agents and Chemotherapy 44, 891-7.
7. Iyobe, S., Kusadokoro, H., Ozaki, J., Matsumura, N., Minami, S., Haruta, S. et al. (2000). Amino acid substitutions in a variant of IMP-1 metallo-β-lactamase. Antimicrobial Agents and Chemotherapy 44, 2023-7.
8. Chu, Y. W., Afzal-Shah, M., Houang, E. T. S., Palepou, M.-F.I., Lyon, D. J., Woodford, N. et al. (2001). IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrobial Agents and Chemotherapy 45, 710-4.
9. Hawkey, P. M., Xiong, J., Ye, H., Li, H. & M'Zali, F. H. (2001). Occurrence of a new metallo-β-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China. FEMS Microbiology Letters 194, 53-7.
10. Yano, H., Kuga, A., Okamoto, R., Kitasato, H., Kobayashi, T. & Inoue, M. (2001). Plasmid-encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrobial Agents and Chemotherapy 45, 1343-8.
11. Yan, J. J., Ko, W. C. & Wu, J. J. (2001). Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-β-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 45, 2368-71.
12. Yan, J. J., Hsueh, P. R., Ko, W. C., Luh, K. T., Tsai, S. H., Wu, H. M. et al. (2001). Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrobial Agents and Chemotherapy 45, 2224-8.
13. IMP-7. Antimicrobial Agents and Chemotherapy 46, 255-8.
14. IMP among clinical isolated strains of Serratia marcescens. Antimicrobial Agents and Chemotherapy 39, 824-9.
15. Senda, K., Arakawa, Y., Nakashima, K., Ito, H., Ichiyama, S., Shimokata, K. et al. (1996). Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum-β-lactams, including carbapenems. Antimicrobial Agents and Chemotherapy 40, 349-53.
16. IMP) in Gram-negative rods resistant to broad-spectrum β-lactams. Journal of Clinical Microbiology 34, 2909-13.
17. IMP. Antimicrobial Agents and Chemotherapy 42, 2006-11.
18. Koh, T. H., Babini, G. S., Woodford, N., Sng, L. H., Hall, L. M. C. & Livermore, D. M. (1999). Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore. Lancet 353, 2162.
19. Tsakris, A., Pournaras, S., Woodford, N., Palepou, M.-F. I., Babini, G. S., Douboyas, J. et al. (2000). Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. Journal of Clinical Microbiology 38, 1290-2.
20. Cornaglia, G., Mazzariol, A., Lauretti, L., Rossolini, G. M. & Fontana, R. (2000). Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clinical Infectious Diseases 31, 1119-25.
21. Lee, K., Lim, J. B., Yum, J., Yong, D., Choi, J. R., Chong, Y. et al. (2000). Emergence of VIM metallo-β-lactamase-producing Pseudomonas and Acinetobacter in Korea. In Program and Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 2000. Abstract 2003, p. 232. American Society for Microbiology, Washington, DC, USA.
22. Arakawa, Y., Shibata, N., Shibayama, K., Kurokawa, H., Yagi, T., Fujuwara, H. et al. (2000). Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thio compounds. Journal of Clinical Microbiology 38, 40-3.
23. IMP-8 in a university medical center in Taiwan. Journal of Clinical Microbiology 39, 4433-9.
24. National Committee for Clinical Laboratory Standards. (2000). Performance Standards for Antimicrobial Disk Susceptibility Tests-Seventh Edition: Approved Standard M2-A7. NCCLS, Wayne, PA, USA.
25. Farmer, J. J., III. (1999). Enterobacteriaceae: introduction and identification. In Manual of Clinical Microbiology, 6th edn (Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 442-58. American Society for Microbiology, Washington, DC, USA.
26. Takahashi, S. & Nagano, Y. (1984). Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. Journal of Clinical Microbiology 20, 608-13.
27. Yan, J. J., Wu, S. M., Tsai, S. H., Wu, J. J. & Su, I. J. (2000). Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamase and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan. Antimicrobial Agents and Chemotherapy 44, 1438-42.
28. Bachmann, B. J. & Low, K. B. (1980). Linkage map of Escherichia coli K-12, edition 6. Microbiology Reviews 44, 1451-6.
29. Bauernfeind, A., Grimm, H. & Schweighart, S. (1990). A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18, 294-8.
30. Matthew, M., Harris, M., Marshall, M. J. & Rose, G. W. (1975). The use of analytical isoelectric focusing for detection and identification of β-lactamases. Journal of General Microbiology 88, 169-78.
31. Southern, E. M. (1975). Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98, 503-17.
32. Popovic, T., Bopp, C. A., Olsvik, Ø. & Kiehlbauch, J. A. (1993). Ribotyping in molecular epidemiology. In Diagnostic Molecular Microbiology: Principles and Applications (Persing, D. H., Smith, T. F., Tenover, F. C. & White, T. J., Eds), pp. 573-94. American Society for Microbiology, Washington, DC, USA.
33. Grattard, F., Pozzetto, B., Berthelot, P., Rayet, I., Ros, A., Lauras, B. et al. (1994). Arbitrarily primed PCR, ribotyping, and plasmid pattern analysis applied to investigation of a nosocomial outbreak due to Enterobacter cloacae in a neonatal intensive care unit. Journal of Clinical Microbiology 32, 596-602.
34. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
35. Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39, 1211-33.
36. Pitout, J. D. D., Moland, E. S., Sanders, C. C., Thomson, K. S. & Fitzsimmons, S. R. (1997). β-Lactamases and detection of β-lactam resistance in Enterobacter spp. Antimicrobial Agents and Chemotherapy 41, 35-9.
37. Garaizar, J., Kaufmann, M. E. & Pitt, T. L. (1991). Comparison of ribotyping with conventional methods for the type identification of Enterobacter cloacae. Journal of Clinical Microbiology 29, 1303-7.
38. Werner, V., Sanders, C. C., Sanders, W. E., Jr & Goering, R. V. (1985). Roles of β-lactamases and outer membrane proteins in multiple β-lactam resistance of Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 27, 455-9.
39. Lee, E. H., Nicolas, M. H., Kitzid, M. D., Pialoux, G., Collatz, E. & Gutmann, L. (1991). Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrobial Agents and Chemotherapy 35, 1093-8.
40. Livermore, D. M. & Woodford, N. (2000). Carbapenemases: a problem in waiting? Current Opinion in Microbiology 3, 489-95.
41. Koh, T. H., Sng, L. H., Babini, G. S., Woodford, N., Livermore, D. M. & Hall, L. M. C. (2001). Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 β-lactamase and lacking an outer membrane protein. Antimicrobial Agents and Chemotherapy 45, 1939-40.